knowledge -WSS

knowledge

author：entertainment 2025-10-02 00:42:16 - browse：95

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout LOUD podcast: Pharma in Washington, Alnylam, and Gilead

WSS

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

WATCH: Why do our ears pop?

Report captures long Covid’s disabling effects and policy challenges

Medicare Advantage enrollment grows 7.1% to 33.4 million people

The system is set up to fail children with medical complexity

Curing rare childhood diseases will falter unless Congress steps up

hotspot

knowledge

focus

Supreme Court strikes down use of affirmative action

How faith leaders like me can help address America's obesity epidemic

State Dept. review finds Biden bears some blame for Afghanistan failures

'Essentially witchcraft:' A former naturopath takes on the field

Wildfire smoke exposes gaps in outdoor worker protections

Moderna says combo Covid

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Cheap, fast test for Zika and dengue could cost just $1

Medical records are filled with copy

Lilly's Alzheimer's drug donanemab backed by FDA advisers

entertainment

As AI regulations shape up, health tech startups beg for clarity

Coercive sterilizations revealed by STAT prompt outrage

Researchers tackle phage therapy hurdles for wider adoption

Stephen Quake on the Chan Zuckerberg quest to conquer disease

Flagship Pioneering startup Sonata Therapeutics lays off 21

Deposition: Sackler embraced plan to conceal OxyContin’s strength

leisure time

knowledge

Wikipedia

Wikipedia